Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made. LPI (LP Information)' newest research report, the ﾓPoint of Care Testing Industry Forecastﾔ looks at past sales and reviews total world Point of Care Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Point of Care Testing sales for 2023 through 2029. With Point of Care Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Point of Care Testing industry. This Insight Report provides a comprehensive analysis of the global Point of Care Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Point of Care Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firmsﾒ unique position in an accelerating global Point of Care Testing market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Point of Care Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Point of Care Testing. The global Point of Care Testing market size is projected to grow from US$ 25110 million in 2022 to US$ 29620 million in 2029; it is expected to grow at a CAGR of 2.4% from 2023 to 2029. Global Point-of-Care Testing (POCT) main players are Roche, Abbott, Johnson & Johnson, etc. Global top three manufacturers hold a share over 45%. North America is the largest market, with a share nearly 51%. This report presents a comprehensive overview, market shares, and growth opportunities of Point of Care Testing market by product type, application, key players and key regions and countries. Market Segmentation: Segmentation by type Blood Glucose Test Pregnancy Test Infectious Factor Test Cardiac Marker Test Blood Chemistry Test Others Segmentation by application Hosptial Home Care This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Roche Diagnostics Radiometer Beckman Abbott Siemens Healthcare Diagnostics Johnson & Johnson Alfa Wassermann Nova Biomedical Alere Accriva
1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Point of Care Testing Market Size 2018-2029 2.1.2 P
